根据高风险复发因素和局部高级直肠癌的动态风险评估,制定个性化后续策略
Jianjian Qiu1, Yilin Yu1, Zhiping Wang1
1Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Cancer medicine
|October 28, 2024
概括
这项研究确定了像PNI和EMVI这样的关键因素,可以预测局部晚期直肠癌 (LARC) 的复发. 一个新的战略提供了个性化的后续行动,以改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 结直肠癌研究 结直肠癌研究
- 临床预后 临床预后
背景情况:
- 局部晚期直肠癌 (LARC) 尽管得到治疗,但其复发率很高.
- 目前针对LARC的后续策略缺乏标准化,并存在局限性.
- 识别高风险因素对于改善患者管理至关重要.
研究的目的:
- 分析与LARC复发相关的临床,营养和成像因素.
- 使用条件生存 (CS) 评估开发个性化的后续策略.
- 评估LARC患者治疗后的动态生存和复发风险.
主要方法:
- 多变量逻辑回归确定了独立的复发因子.
- 诺莫格拉姆模型和风险分层被用于预测.
- 条件生存率 (CS) 和卡普兰-梅尔曲线评估了生存结果.
主要成果:
- 预后营养指数 (PNI),外壁血管侵袭 (EMVI) 和瘤特征是独立的复发预测因素.
- 一个预测模型证明了良好的疗效 (AUC=0.763).
- 根据风险分层和累计复发风险,制定了个性化后续策略.
结论:
- 风险分层,个性化的随访优化了LARC患者的资源使用.
- 通过量身定制的策略,可以提升复发/转移的早期检测.
- 预计LARC患者的整体护理和预后将得到改善.
相关概念视频
Appendicitis-II: Diagnostic Studies and Management
66
Diagnosing and managing appendicitis requires a structured and comprehensive approach that spans from initial assessment to postoperative care. Here is an overview of the process:
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
66
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328


